The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Expression, regulation, and function of exosome‐derived miRNAs in cancer progression and therapy
Open accessAbstract
Exosomes are a novel class of intercellular signal modulators that contain a wide range of molecules and deliver information between cells and tissues. MicroRNAs (miRNAs), a type of regulatory non‐coding RNA, are often incorporated into exosomes as signaling molecules. In this review, we discuss the expression of exosomal miRNAs from diverse origins such as tumor cells, solid tumor tissue, and biological fluids in various cancers (lung, breast, colorectal, liver, stomach, and pancreatic). We address the biological functions of exosome‐derived miRNAs in processes such as tumor‐cell proliferation, angiogenesis, metastasis, and chemoresistance in the tumor microenvironment. In particular, we discuss three oncogenic miRNAs, miR‐21, miR‐141, and miR‐451, which occur within exosomes, in terms of gene regulation and intercellular communication. We consider therapeutic miRNA‐based nanoparticles, which are widely expressed in tumors and show promise in drug therapy. The review assesses the wide‐ranging evidence for using exosomal miRNAs as tumor markers in molecular diagnosis. Further, we consider the use of nanoparticle platforms to transport miRNAs, in the targeted treatment of disease and tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Liu, T., Zhang, X., Du, L., Wang, Y., Liu, X., Tian, H., Wang, L., Li, P., Zhao, Y., Duan, W., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0981-7 · Cited by 264
RetractedLi, Z., Chen, H., Xia, H., Xu, X., Gu, J., Jin, T., & Gui, Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119339 · Cited by 24
Retracted(2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26657 · Cited by 14
RetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346
miRBase: from microRNA sequences to function
Kozomara, A., Birgaoanu, M., & Griffiths-Jones, S. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1141 · Cited by 4,843
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
Tkach, M., & Théry, C. (2016) · Cell · doi:10.1016/j.cell.2016.01.043 · Cited by 3,444
An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans
Lau, N. C., Lim, L. P., Weinstein, E. G., & Bartel, D. P. (2001) · Science · doi:10.1126/science.1065062 · Cited by 3,345
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
Basic and Therapeutic Aspects of Angiogenesis
Potente, M., Gerhardt, H., & Carmeliet, P. (2011) · Cell · doi:10.1016/j.cell.2011.08.039 · Cited by 2,771
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017) · Nature · doi:10.1038/nature22341 · Cited by 2,639
MicroRNA biogenesis pathways in cancer
Lin, S., & Gregory, R. I. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3932 · Cited by 2,112
CAI, X., HAGEDORN, C. H., & CULLEN, B. R. (2004) · RNA · doi:10.1261/rna.7135204 · Cited by 1,872
Exosomes: proteomic insights and diagnostic potential
Simpson, R. J., Lim, J. W., Moritz, R. L., & Mathivanan, S. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.17 · Cited by 1,108
Exfoliation of membrane ecto-enzymes in the form of micro-vesicles
Trams, E. G., Lauter, C. J., Norman Salem, Jr., & Heine, U. (1981) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(81)90512-5 · Cited by 1,093
Lipids in exosomes: current knowledge and the way forward
Skotland, T., Sandvig, K., & Llorente, A. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.03.001 · Cited by 1,030
Fang, T., Lv, H., Lv, G., Li, T., Wang, C., Han, Q., Yu, L., Su, B., Guo, L., Huang, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02583-0 · Cited by 995
Zeng, Z., Li, Y., Pan, Y., Lan, X., Song, F., Sun, J., Zhou, K., Liu, X., Ren, X., Wang, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07810-w · Cited by 992
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
Huang, X., Yuan, T., Liang, M., Du, M., Xia, S., Dittmar, R., Wang, D., See, W., Costello, B. A., Quevedo, F., et al. (2015) · European Urology · doi:10.1016/j.eururo.2014.07.035 · Cited by 681
Hurley, J. H. (2015) · The EMBO Journal · doi:10.15252/embj.201592484 · Cited by 666
Lou, G., Song, X., Yang, F., Wu, S., Wang, J., Chen, Z., & Liu, Y. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0220-7 · Cited by 651
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer
Lan, J., Sun, L., Xu, F., Liu, L., Hu, F., Song, D., Hou, Z., Wu, W., Luo, X., Wang, J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-0014 · Cited by 643
Zheng, P., Chen, L., Yuan, X., Luo, Q., Liu, Y., Xie, G., Ma, Y., & Shen, L. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0528-y · Cited by 629
Plasma exosome microRNAs are indicative of breast cancer
Hannafon, B. N., Trigoso, Y. D., Calloway, C. L., Zhao, Y. D., Lum, D. H., Welm, A. L., Zhao, Z. J., Blick, K. E., Dooley, W. C., & Ding, W. Q. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0753-x · Cited by 603
Li, L., Li, C., Wang, S., Wang, Z., Jiang, J., Wang, W., Li, X., Chen, J., Liu, K., Li, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1625 · Cited by 532
Yan, W., Wu, X., Zhou, W., Fong, M. Y., Cao, M., Liu, J., Liu, X., Chen, C.-H., Fadare, O., Pizzo, D. P., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0083-6 · Cited by 469
Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
Matsumura, T., Sugimachi, K., Iinuma, H., Takahashi, Y., Kurashige, J., Sawada, G., Ueda, M., Uchi, R., Ueo, H., Takano, Y., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.201 · Cited by 453
miR-21 as a key regulator of oncogenic processes
Selcuklu, S. D., Donoghue, M. T. A., & Spillane, C. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370918 · Cited by 445
Qin, X., Guo, H., Wang, X., Zhu, X., Yan, M., Wang, X., Xu, Q., Shi, J., Lu, E., Chen, W., et al. (2019) · Genome Biology · doi:10.1186/s13059-018-1604-0 · Cited by 431
Zhu, X., Shen, H., Yin, X., Yang, M., Wei, H., Chen, Q., Feng, F., Liu, Y., Xu, W., & Li, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1095-1 · Cited by 374
Li, Y.-Y., Tao, Y.-W., Gao, S., Li, P., Zheng, J.-M., Zhang, S.-E., Liang, J., & Zhang, Y. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.006 · Cited by 342
Gong, C., Tian, J., Wang, Z., Gao, Y., Wu, X., Ding, X., Qiang, L., Li, G., Han, Z., Yuan, Y., et al. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0526-7 · Cited by 339
Binenbaum, Y., Fridman, E., Yaari, Z., Milman, N., Schroeder, A., Ben David, G., Shlomi, T., & Gil, Z. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0124 · Cited by 337
Fang, J., Zhang, Z., Shang, L., Luo, Y., Lin, Y., Yuan, Y., & Zhuang, S. (2018) · Hepatology · doi:10.1002/hep.29920 · Cited by 335
Johnstone, R., Bianchini, A., & Teng, K. (1989) · Blood · doi:10.1182/blood.v74.5.1844.1844 · Cited by 289
Guo, X., Qiu, W., Liu, Q., Qian, M., Wang, S., Zhang, Z., Gao, X., Chen, Z., Xue, H., & Li, G. (2018) · Oncogene · doi:10.1038/s41388-018-0261-9 · Cited by 287
Plebanek, M. P., Angeloni, N. L., Vinokour, E., Li, J., Henkin, A., Martinez-Marin, D., Filleur, S., Bhowmick, R., Henkin, J., Miller, S. D., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01433-3 · Cited by 285
Zhang, Z., Li, X., Sun, W., Yue, S., Yang, J., Li, J., Ma, B., Wang, J., Yang, X., Pu, M., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.004 · Cited by 260
Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities
Salehi, M., & Sharifi, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26481 · Cited by 251
Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma
Lee, Y. R., Kim, G., Tak, W. Y., Jang, S. Y., Kweon, Y. O., Park, J. G., Lee, H. W., Han, Y. S., Chun, J. M., Park, S. Y., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.31931 · Cited by 250
Tian, X.-P., Wang, C.-Y., Jin, X.-H., Li, M., Wang, F.-W., Huang, W.-J., Yun, J.-P., Xu, R.-H., Cai, Q.-Q., & Xie, D. (2019) · Theranostics · doi:10.7150/thno.30958 · Cited by 246
Exosome miR‐335 as a novel therapeutic strategy in hepatocellular carcinoma
Wang, F., Li, L., Piontek, K., Sakaguchi, M., & Selaru, F. M. (2018) · Hepatology · doi:10.1002/hep.29586 · Cited by 231
Liu, C., Liu, R., Zhang, D., Deng, Q., Liu, B., Chao, H.-P., Rycaj, K., Takata, Y., Lin, K., Lu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14270 · Cited by 228
Lin, X.-J., Fang, J.-H., Yang, X.-J., Zhang, C., Yuan, Y., Zheng, L., & Zhuang, S.-M. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.02.014 · Cited by 225
Kanlikilicer, P., Bayraktar, R., Denizli, M., Rashed, M. H., Ivan, C., Aslan, B., Mitra, R., Karagoz, K., Bayraktar, E., Zhang, X., et al. (2018) · eBioMedicine · doi:10.1016/j.ebiom.2018.11.004 · Cited by 220
Li, Q., Li, B., Li, Q., Wei, S., He, Z., Huang, X., Wang, L., Xia, Y., Xu, Z., Li, Z., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0928-8 · Cited by 219
Self-citationBao, L., You, B., Shi, S., Shan, Y., Zhang, Q., Yue, H., Zhang, J., Zhang, W., Shi, Y., Liu, Y., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0183-6 · Cited by 206
Zeng, A., Wei, Z., Yan, W., Yin, J., Huang, X., Zhou, X., Li, R., Shen, F., Wu, W., Wang, X., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.004 · Cited by 192
Hsieh, C.-H., Tai, S.-K., & Yang, M.-H. (2018) · Neoplasia · doi:10.1016/j.neo.2018.06.004 · Cited by 185
Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth
Cao, L.-Q., Yang, X.-W., Chen, Y.-B., Zhang, D.-W., Jiang, X.-F., & Xue, P. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1075-2 · Cited by 184
Li, C., Wan, L., Liu, Z., Xu, G., Wang, S., Su, Z., Zhang, Y., Zhang, C., Liu, X., Lei, Z., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.036 · Cited by 181
Fetal Bovine Serum RNA Interferes with the Cell Culture derived Extracellular RNA
Wei, Z., Batagov, A. O., Carter, D. R. F., & Krichevsky, A. M. (2016) · Scientific Reports · doi:10.1038/srep31175 · Cited by 178
Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer
Mao, G., Liu, Y., Fang, X., Liu, Y., Fang, L., Lin, L., Liu, X., & Wang, N. (2015) · Angiogenesis · doi:10.1007/s10456-015-9474-5 · Cited by 171
The Clinical Application of MicroRNAs in Infectious Disease
Drury, R. E., O’Connor, D., & Pollard, A. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01182 · Cited by 171
Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice
Zuo, B., Qi, H., Lu, Z., Chen, L., Sun, B., Yang, R., Zhang, Y., Liu, Z., Gao, X., You, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15569-2 · Cited by 170
Yin, H., Xiong, G., Guo, S., Xu, C., Xu, R., Guo, P., & Shu, D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.04.018 · Cited by 165
MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma
Liu, C., Yu, J., Yu, S., Lavker, R. M., Cai, L., Liu, W., Yang, K., He, X., & Chen, S. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.021 · Cited by 164
Reshke, R., Taylor, J. A., Savard, A., Guo, H., Rhym, L. H., Kowalski, P. S., Trung, M. T., Campbell, C., Little, W., Anderson, D. G., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0502-4 · Cited by 161
Cancer-secreted exosomal miR-21-5p induces angiogenesis and vascular permeability by targeting KRIT1
He, Q., Ye, A., Ye, W., Liao, X., Qin, G., Xu, Y., Yin, Y., Luo, H., Yi, M., Xian, L., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03803-8 · Cited by 159
Xie, Y., Hang, Y., Wang, Y., Sleightholm, R., Prajapati, D. R., Bader, J., Yu, A., Tang, W., Jaramillo, L., Li, J., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b03978 · Cited by 158
Yang, H., Fu, H., Wang, B., Zhang, X., Mao, J., Li, X., Wang, M., Sun, Z., Qian, H., & Xu, W. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22838 · Cited by 149
Wang, X., Shen, H., Zhangyuan, G., Huang, R., Zhang, W., He, Q., Jin, K., Zhuo, H., Zhang, Z., Wang, J., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0180-7 · Cited by 146
Li, D., Wang, J., Zhang, M., Hu, X., She, J., Qiu, X., Zhang, X., Xu, L., Liu, Y., & Qin, S. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.11.003 · Cited by 146
Li, M., Zhou, Y., Xia, T., Xin Min, Z. H. O. U., Huang, Z., Zhang, H., Zhu, W., Ding, Q., & Wang, S. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4757-3 · Cited by 134
Nanoplasmonic sensors for detecting circulating cancer biomarkers
Ferhan, A. R., Jackman, J. A., Park, J. H., Cho, N., & Kim, D. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.004 · Cited by 126
Huang, S., Wa, Q., Pan, J., Peng, X., Ren, D., Huang, Y., Chen, X., & Tang, Y. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0645-7 · Cited by 118
Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer
Wang, W., Zhang, L., Wang, Y., Ding, Y., Chen, T., Wang, Y., Wang, H., Li, Y., Duan, K., Chen, S., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.460 · Cited by 116
miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2
Zhao, Q., Chen, S., Zhu, Z., Yu, L., Ren, Y., Jiang, M., Weng, J., & Li, B. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1182-9 · Cited by 113
Self-citationNi, S.-J., Zhao, L.-Q., Wang, X. F., Wu, Z.-H., Hua, R., Wan, C., Zhang, J., Zhang, X.-W., Huang, M., Gan, L., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0562-z · Cited by 111
Serum exosomal miR‐210 as a potential biomarker for clear cell renal cell carcinoma
Wang, X., Wang, T., Chen, C., Wu, Z., Bai, P., Li, S., Chen, B., Liu, R., Zhang, K., Li, W., et al. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27347 · Cited by 106
Peng, Z., Gu, R., & Yan, B. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27291 · Cited by 105
Xu, K., Han, B., Bai, Y., Ma, X., Ji, Z., Xiong, Y., Miao, S.-K., Zhang, Y., & Zhou, L. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1403-x · Cited by 99
The biology, function and clinical implications of exosomes in lung cancer
Zhou, L. Q., Lv, T., Zhang, Q., Zhu, Q., Zhan, P., Zhu, S., Zhang, J., & Song, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.003 · Cited by 97
Shah, K. B., Chernausek, S. D., Garman, L., Pezant, N. P., Plows, J. F., Kharoud, H., Demerath, E. W., & Fields, D. A. (2021) · Nutrients · doi:10.3390/nu13041091 · Cited by 97
Urinary exosome microRNA signatures as a noninvasive prognostic biomarker for prostate cancer
Shin, S. Y., Park, Y. H., Jung, S., Jang, S., Kim, M. Y., Lee, J. Y., & Chung, Y. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00212-w · Cited by 96
Liu, X., Zhang, A., Xiang, J., Lv, Y., & Zhang, X. (2016) · Oncology Reports · doi:10.3892/or.2016.4971 · Cited by 93
Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapy
Malla, B., Aebersold, D. M., & Pra, A. D. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1592-6 · Cited by 92
Yin, H., Wang, H., Li, Z., Shu, D., & Guo, P. (2018) · ACS Nano · doi:10.1021/acsnano.8b07948 · Cited by 90
Cai, J., Gong, L., Li, G., Guo, J., Yi, X., & Wang, Z. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03490-5 · Cited by 89
Wu, L., Pan, C., Wei, X., Shi, Y., Zheng, J., Lin, X., & Shi, L. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0260-z · Cited by 82
Long and Short Non-Coding RNAs as Regulators of Hematopoietic Differentiation
Morceau, F., Chateauvieux, S., Gaigneaux, A., Dicato, M. A., & Diederich, M. F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714744 · Cited by 81
Wu, M. Y., Chen, Z.-K., Xie, Q., Xiao, B.-L., Zhou, G., Chen, G., & Bian, Z. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112733 · Cited by 80
Zhu, M., Wang, X., Gu, Y., Wang, F., Li, L., & Qiu, X. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.10.021 · Cited by 76
Cui, Z., An, X., Li, J., Liu, Q., & Liu, W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.046 · Cited by 72
Wang, H., Li, H., Zhang, L., & Yang, D. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.131 · Cited by 71
Dang, E., Yang, S., Song, C., Jiang, D., Li, Z., Fan, W., Sun, Y., Tao, L., Wang, J., Liu, T., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0824-2 · Cited by 67
Mousavi, S., Moallem, R., Hassanian, S. M., Sadeghzade, M., Mardani, R., Ferns, G. A., Khazaei, M., & Avan, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28080 · Cited by 67
Wischhusen, J. C., Chowdhury, S. M., Lee, T., Wang, H., Bachawal, S. V., Devulapally, R., Afjei, R., Sukumar, U. K., & Paulmurugan, R. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.051 · Cited by 66
Urinary exosomal microRNA profiling in intermediate-risk prostate cancer
Kim, M. Y., Shin, H., Moon, H. W., Park, Y. H., Park, J., & Lee, J. Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-86785-z · Cited by 64
Zeng, B., Li, Y., Jiang, F., Wei, C., Chen, G., Zhang, W., Zhao, W., & Yu, D. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.12.014 · Cited by 61
KRAS induces lung tumorigenesis through microRNAs modulation
Shi, L., Middleton, J. D., Jeon, Y.-J., Magee, P., Veneziano, D., Laganà, A., Leong, H. S., Sahoo, S., Fassan, M., Booton, R., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0243-9 · Cited by 60
The regulatory network of miR-141 in the inhibition of angiogenesis
Dong, H., Weng, C., Bai, R., Sheng, J., Gao, X., Li, L., & Xu, Z. (2018) · Angiogenesis · doi:10.1007/s10456-018-9654-1 · Cited by 60
Exosomal non-coding RNAs: a promising cancer biomarker
Yang, H., Fu, H., Xu, W., & Zhang, X. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0029 · Cited by 52
Mantilla-Escalante, D. C., Hazas, M. L. D. L., Crespo, M. C., Martín‐Hernández, R., Tomé‐Carneiro, J., del Pozo‐Acebo, L., Salas‐Salvadó, J., Bulló, M., & Dávalos, A. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02594-0 · Cited by 51
Ding, T., Cui, P., Zhou, Y., Chen, C., Zhao, J., Wang, H., Guo, M., He, Z., & Xu, L. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.09.004 · Cited by 50
Liu, B., Cao, W., & Ma, H. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1626404 · Cited by 43
Liu, Y., Zhao, R., Wei, Y., Li, M., Wang, H., Niu, W., Zhou, Y., Qiu, Y., Fan, S., Zhan, Y., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0734-2 · Cited by 42
Recent progress in the emerging role of exosome in hepatocellular carcinoma
Abudoureyimu, M., Zhou, H., Zhi, Y., Wang, T., Feng, B. C., Wang, R., & Chu, X. (2018) · Cell Proliferation · doi:10.1111/cpr.12541 · Cited by 42
Zhang, C., Cao, J., Lv, W., & Mou, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.663147 · Cited by 42
LINC 00312 represses proliferation and metastasis of colorectal cancer cells by regulation of miR‐21
Li, G., Wang, C., Wang, Y., Xu, B., & Zhang, W. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13830 · Cited by 41
Zennami, K., Choi, S., Liao, R. S., Li, Y., Dinalankara, W., Marchionni, L., Rafiqi, F. H., Kurozumi, A., Hatano, K., & Lupold, S. E. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0837 · Cited by 40
Kaiser, J. (2016) · Science · doi:10.1126/science.352.6282.164 · Cited by 39
Uchida, A., Seki, N., Mizuno, K., Yamada, Y., Misono, S., Sanada, H., Kikkawa, N., Kumamoto, T., Suetsugu, T., & Inoue, H. (2019) · Cancers · doi:10.3390/cancers11020258 · Cited by 36
Zhang, Y., Lu, W., Chen, Y., Lin, Y., Yang, X., Wang, H., & Liu, Z. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12934 · Cited by 35
Usmani, A., Shoro, A. A., Memon, Z., Hussain, M., & Rehman, R. (2015) · Europe PMC (PubMed Central) · Cited by 31
Ten-eleven translocation 1 (TET1) gene is a potential target of miR-21-5p in human colorectal cancer
Cheng, Y., Chou, C.-J., & Yang, P. (2018) · Surgical Oncology · doi:10.1016/j.suronc.2017.12.004 · Cited by 29
A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer
Liu, L., Pang, H., He, Q., Pan, B., Sun, X., Shan, J., Wu, L., Wu, K., Yao, X., & Guo, Y. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02007-6 · Cited by 29
Κουτσιούμπα, Μ., Chen, H., O’Brien, N. A., Koinis, F., Mahurkar‐Joshi, S., Vorvis, C., Soroosh, A., Luo, T., Issakhanian, S., Pantuck, A. J., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1049 · Cited by 25
Li, X., Tian, Z., Jin, H., Xu, J., Hua, X., Yan, H., Liufu, H., Wang, J., Li, J., Zhu, J., et al. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00273-18 · Cited by 22
Zhou, B., Guo, M., Hao, X., Lou, B., Liu, J., & She, J. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-2375 · Cited by 4
Cited by
Bai, R., Li, Y., Jian, L., Yang, Y., Zhao, L., & Wei, M. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01645-2 · Cited by 279
Recent advances in exosome-based immunotherapy applied to cancer
Xie, J., Zheng, Z., Tuo, L., Deng, X., Tang, H., Peng, C., & Zou, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1296857 · Cited by 40
Metadata
- Authors
- Li, B., Cao, Y., Sun, M., & Feng, H.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2021-09-12
- Volume
- 35
- Issue
- 10
- Pages
- e21916-e21916
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W3201233503
- Cited by
- 262
- References
- 113
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.